Inhibition of HIV-1 integrase by small molecules: The potential for a new class of AIDS chemotherapeutics

Current Opinion in Drug Discovery and Development

Volumn 4, Issue 4, 2001, Pages 402-410

  Young, S D ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Acquired immunodeficiency syndrome; AIDS; Antiviral agent; HIV 1 integrase; Integrase inhibitor; Retroviral integrase

Indexed keywords

1,3 PROPANEDIONE DERIVATIVE; 2,4 DIKETOBUTANOIC ACID DERIVATIVE; AURINTRICARBOXYLIC ACID; BETA CONIDENDROL; CICHORIC ACID; INTEGRASE; INTEGRASE INHIBITOR; LIGNANOLIDE; PROTEINASE; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS ENZYME;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CELL CULTURE; CHEMOTHERAPY; DRUG SCREENING; ENZYME INHIBITION; ENZYME STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; REVIEW; STRUCTURE ACTIVITY RELATION; VIROGENESIS; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ANTI-HIV AGENTS; ENZYME INHIBITORS; HIV INTEGRASE; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034911386     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Human immunodeficiency viruses and their replication
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
3. HIV chemotherapy
4. Disease model: Pulmonary tuberculosis
5. HIV integrase structure and function
6. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding
7. Requirement of active human immunodeficiency virus type I integrase enzyme for productive infection of human T-lymphoid cells
8. A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vivo
9. HIV-1 integrase: Structural organization, conformational changes, and catalysis
10. Human immunodeficiency virus type 1 preintegration complexes: Studies of organization and composition
11. The role of manganese in promoting multimerization and assembly of human immunodeficiency virus type 1 integrase as a catalytically active complex on immobilized long terminal repeat substrates
12. A metal-induced conformational change and activation in HIV-1 integrase
13. Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase
14. Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules
15. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase
16. Solution structure of the DNA binding domain of HIV-1 integrase
17. Crystal structure of the catalytic domain of HIV-1 integrase: Similarity to other polynucleotidyl transferases
18. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293) - An initial glance of the viral DNA binding platform
19. Purification, solution properties and crystallization of SIV integrase containing a continuous core and C-terminal domain
20. Inhibitors of human immunodeficiency virus integrase
21. Structure-based HIV-1 integrase inhibitor design: A future perspective
22. Retroviral integrase inhibitors year 2000: Update and perspectives
23. Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds
24. Inhibition of human immunodeficiency virus integrase by bis-catechols
25. (-) Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase
26. Structure-activity relationships: Analogs of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication
27. Chicoric acid analogs as HIV-1 integrase inhibitors
28. Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra acetyl esters
29. A new class of HIV-1 integrase inhibitors: The 3,3,3′,3′- tetramethyl-1,1′-spirobi(indan)-5,5′,6,6′-tetrol family
30. Metal activation of enzymes in nucleic acid biochemistry
31. Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture
32. Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives
33. Thiazolothiazepine inhibitors of HIV-1 integrase
34. Lamellarin α 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture
35. Recognition and inhibition of HIV integrase by novel dinucleotides
36. Inhibition of HIV-1 integrase-catalyzed reaction by new DNA minor groove ligands: The oligo-1,3-thiazolecarboxamide derivatives
37. Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors
38. Mechanism of inhibition of HIV-1 integrase by G-tetrad-forming oligonucleotides in vitro
39. Inhibition of HIV-1 integrase by modified oligonucleotides derived from U5′ LTR
40. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design
41. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
42. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase
43. 4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells